Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Clinical research trials and Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control. Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control clinical trial. Participants oftentimes recieve the most expert healthcare available for their Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control



Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

For Condition: Diabetes Mellitus, Type 1
Status: No longer recruiting
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - HbA1c value between 7.5-9% - Using multiple daily insulin injections
Total Enrollment: 

Location and Contact Information:

Private Practice
Lufkin,  Texas, 
United States
 

East Bay Clinical Trial Center
Concord,  California, 
United States
 

Indiana University Outpatient Clinical Research
Indianapolis,  Indiana, 
United States
 

Internal Medicine Associates
Ft. Myers,  Florida, 
United States
 

Medical Research Unlimited
Aventura,  Florida,  33180
United States
 

Diabetes Research Institute
San Mateo,  California, 
United States
 

Phoenix Endocrinology Clinic, Ltd.
Phoenix,  Arizona,  85006
United States
 

Sansum Medical Research Institute
Santa Barbara,  California, 
United States
 

Children's Clinic
Tallahassee,  Florida, 
United States
 

Mercury Street Medical
Butte,  Montana, 
United States
 

UCSD Diabetes Research Center
San Diego,  California, 
United States
 

Diablo Clinical Research
Walnut Creek,  California, 
United States
 

St. James Diabetes Center
Chicago,  Illinois,  60411
United States
 

Radiant Research
St. Louis,  Missouri,  63141
United States
 

Rainier Clinical Research Center
Renton,  Washington, 
United States
 

Medical Research Unlimited
Aventura,  Florida, 
United States
 

UNC Diabetes Care Center
Durham,  North Carolina,  27713
United States
 

Private Practice
Lufkin,  Texas,  75904
United States
 

Valley Research
Fresno,  California, 
United States
 

North Texas Clinical Research
Irving,  Texas, 
United States
 

Henry Ford Health System
Detroit,  Michigan, 
United States
 

Suncoast Clinical Research
New Port Richey,  Florida, 
United States
 

Ohio State Univ.-Division of Endocrinology, Diabetes
Columbus,  Ohio,  43210
United States
 

Vanderbilt University Medical Center
Nashville,  Tennessee, 
United States
 

Barbara Davis Center for Childhood Diabetes
Denver,  Colorado,  80262
United States
 

St. James Diabetes Center
Chicago,  Illinois, 
United States
 

Radiant Research
Portland,  Oregon, 
United States
 

Atlanta Diabetes Associates
Atlanta,  Georgia, 
United States
 

Physicians for Clinical Research
Camp Hill,  Pennsylvania, 
United States
 

Grand Rapids Associated Interns
Grand Rapids,  Michigan, 
United States
 

Ana Ventures LLC
Mesa,  Arizona,  85204
United States
 

MedStar Clinical Research Center
Washington D.C.,  District of Columbia, 
United States
 

University of Maryland Joslin Diabetes Center
Baltimore,  Maryland,  21012
United States
 


Additional Information:
Study ID Numbers:
  137-150; 
Study Start Date: April 2002
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042458

Other Diabetes Mellitus, Type 1 Studies:
1. The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)

2. Evaluation of the Effect of Pramlintide on Satiety and Food Intake

3. Islet Transplantation for patients with Type 1 diabetes

4. Matrix metalloproteinases and Diabetic Nephropathy

5. Evaluation of the Bioavailability of Pramlintide

Related Studies:

Other Diabetes Mellitus, Type 1 Clinical Trials
Other Michigan Clinical Trials
Other Detroit Clinical Trials

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Modify your Search

  Other Diabetes Mellitus, Type 1 Clinical Trials
  Other Michigan Clinical Trials
  Other Detroit Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103